Paul Fitzgerald
About Paul Fitzgerald
Paul Fitzgerald is an Executive Specialist Representative in Immuno-Oncology at Bristol Myers Squibb, with extensive experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Paul Fitzgerald currently holds the position of Executive Specialist Representative Immuno-Oncology at Bristol Myers Squibb. He started this role on May 1, 2020 and has been primarily involved in Immuno-Oncology, bringing his extensive experience to this critical field. At Bristol Myers Squibb, he also takes on responsibilities as an HSR (Healthcare Sales Representative).
Previous Experience at Astellas Pharma
From 2012 to 2014, Paul Fitzgerald worked at Astellas Pharma as a Territory Business Manager in the NSW North region. During his tenure, he focused on promoting medical products and managing business activities within his territory. His role involved liaising with healthcare professionals and ensuring the effective deployment of pharmaceutical solutions.
Past Roles at AstraZeneca
Paul Fitzgerald spent seven years from 2005 to 2012 as a Hospital Specialist Representative at AstraZeneca, covering the NSW East/North region. Prior to this role, he served as a GP Representative (Worker Bee) from 2003 to 2005, focusing on general practitioner engagements. These positions helped him build a solid foundation in hospital and general practice settings, extending his expertise in the pharmaceutical industry.
Academic Background
Paul Fitzgerald earned a Bachelor of Commerce (B.Com.) in Marketing from Western Sydney University between 1993 and 1995. Prior to his degree, he attended St Patrick's College Strathfield, where he completed his Higher School Certificate (HSC) from 1984 to 1992.
Early Career at Bristol-Myers Squibb
Paul Fitzgerald began his professional journey in the pharmaceutical industry as a Medical Sales Representative at Bristol-Myers Squibb, serving from 2000 to 2003. This role marked the start of his extensive career in medical sales, laying the groundwork for his subsequent accomplishments in the field.
Transition to Oncology at Bristol Myers Squibb
Paul Fitzgerald made a significant transition from the cardiovascular team to the Oncology business unit at Bristol Myers Squibb. In this state-based Key Account Management (KAM) role, he leverages his expertise to manage key accounts and drive the success of oncology-related business initiatives.